Delivery Order SPE2DB24D2003-SPE2DB24FXGG3

Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,369.99 firm fixed price contract is for the supply of Sunosi 75 mg tablets to support military healthcare programs. The contract has a period of performance through January 31, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The contract has a ceiling value of $1,727.59 and is for the delivery of 150 mg Sunosi tablets. It is a firm fixed price delivery order contract without any set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and will supply the medication to support federal healthcare programs and facilities. The contract has an ultimate...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Sunosi 150 mg tablets to the government. The firm-fixed-price delivery order, valued at $1,796.57, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of November 4, 2024 and was awarded on November 1, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,322.06, is for the delivery of Sunosi 75 mg tablets. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4562437326 - SUNOSI 75 MG TABLET 30S, a prescription medication, at a ceiling value of $1,842.18. The contract has an ultimate completion date of October 11, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the supply of SUNOSI 75 mg tablets, a specialty pharmaceutical product. The completion date for this delivery order is February 1, 2024, and the potential value is $2,456.97. This delivery order is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,733.05 firm fixed price delivery order is for the supply of the pharmaceutical product Sunosi 75 mg tablets. The award has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sunosi 150 mg tablets, a medication used to treat excessive sleepiness. The contract has a ceiling value of $1,292.17 and a period of performance through April 30, 2025. It is a firm-fixed-price contract, and there is no set-aside designation, indicating open competition....
This $1,299.54 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 75mg Sunosi tablets to support federal healthcare programs. The award has an ultimate completion date of July 24, 2024 and there is no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts with DLA and other agencies, valued up to $999,999,999 and $750,000 respectively,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SUNOSI 75 MG TABLET 30S, a medical product, with a firm fixed price of $4,786.14 and an ultimate completion date of June 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB24D2003
    Indefinite Delivery Contract
  • SPE2DB24D2003-SPE2DB24FXGG3
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Sunosi 150 mg tablets. The $2,139.76 firm fixed-price contract does not have a set-aside designation and has an ultimate completion date of August 19, 2024. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a wide range of pharmaceutical and medical supplies to support military healthcare programs and facilities worldwide. The company has extensive experience in federal contracting, having been awarded numerous contracts by various defense and civilian agencies to deliver critical care materials and a diverse portfolio of medications.

Generated 11/15/24, 9:11 AM